WS MANAGEMENT LLLP - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 70 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WS MANAGEMENT LLLP ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2022$124,000
-37.1%
115,6020.0%0.01%
-31.2%
Q2 2022$197,000
-17.2%
115,6020.0%0.02%
+33.3%
Q1 2022$238,000
-45.2%
115,6020.0%0.01%
-65.7%
Q4 2021$434,000
-27.4%
115,6020.0%0.04%
-44.4%
Q3 2021$598,000
+21.5%
115,6020.0%0.06%
+28.6%
Q2 2021$492,000
-19.9%
115,6020.0%0.05%
-23.4%
Q1 2021$614,000
-6.3%
115,602
-4.9%
0.06%
-5.9%
Q4 2020$655,000
-32.5%
121,5430.0%0.07%
-35.2%
Q3 2020$970,000
-20.3%
121,5430.0%0.10%
-29.5%
Q2 2020$1,217,000
+214.5%
121,543
-14.6%
0.15%
+254.8%
Q1 2020$387,000
+116.2%
142,374
-4.8%
0.04%
+180.0%
Q4 2019$179,000
-20.8%
149,5070.0%0.02%
-16.7%
Q3 2019$226,000
-66.1%
149,507
-9.9%
0.02%
-58.1%
Q2 2019$667,000
-16.4%
165,947
-10.6%
0.04%
-10.4%
Q1 2019$798,000
-34.0%
185,537
-11.8%
0.05%
-18.6%
Q4 2018$1,210,000
-69.9%
210,459
-29.1%
0.06%
-55.3%
Q3 2018$4,024,000
+14.2%
296,7830.0%0.13%
+33.3%
Q2 2018$3,523,000296,7830.10%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$2,341,0003.33%
Matrix Capital Management Company, LP 38,974,185$66,256,0001.50%
NEA Management Company, LLC 17,082,612$29,040,0001.49%
Endurant Capital Management LP 1,824,065$3,101,0001.09%
Long Focus Capital Management, LLC 4,679,491$7,955,0000.83%
Key Client Fiduciary Advisors, LLC 416,166$707,0000.69%
PFM Health Sciences, LP 9,109,780$15,487,0000.59%
ACT CAPITAL MANAGEMENT, LLC 90,000$153,0000.21%
DAFNA Capital Management LLC 351,064$597,0000.16%
Rock Springs Capital Management LP 2,357,544$4,008,0000.12%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders